US4431657A
(en)
*
|
1982-05-24 |
1984-02-14 |
Ayerst, Mckenna & Harrison Inc. |
Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives
|
KR20010086657A
(ko)
*
|
2000-03-02 |
2001-09-15 |
성재갑 |
아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물
|
CA2422377C
(en)
|
2000-09-15 |
2010-04-13 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
ZA200301703B
(en)
*
|
2000-09-15 |
2004-03-02 |
Vertex Pharma |
Pyrazole compounds useful as protein kinase inhibitors.
|
SI1318997T1
(sl)
*
|
2000-09-15 |
2006-12-31 |
Vertex Pharma |
Pirazolne spojine, uporabne kot inhibitorji protein-kinaze
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
EP1345922B1
(en)
|
2000-12-21 |
2006-05-31 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
KR100406634B1
(ko)
*
|
2001-03-12 |
2003-11-20 |
주식회사 엘지생명과학 |
3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도
|
ES2380054T3
(es)
|
2001-09-26 |
2012-05-08 |
Pfizer Italia S.R.L. |
Derivados de aminoindazol activos como inhibidores de quinasas, procedimientos para su preparación, y composiciones farmacéuticas que los contienen
|
ES2437391T3
(es)
*
|
2002-02-06 |
2014-01-10 |
Vertex Pharmaceuticals, Inc. |
Compuestos de heteroarilo útiles como inhibidores de GSK-3
|
FR2836915B1
(fr)
*
|
2002-03-11 |
2008-01-11 |
Aventis Pharma Sa |
Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
|
ATE468336T1
(de)
|
2002-03-15 |
2010-06-15 |
Vertex Pharma |
Azolylaminoazine als proteinkinasehemmer
|
BR0311291A
(pt)
|
2002-05-17 |
2005-03-29 |
Pharmacia Italia Spa |
Derivados de aminoindazol ativos como inibidores da cinase, processo para sua preparação e composições farmacêuticas compreendendo os mesmos
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
KR20050032105A
(ko)
|
2002-08-02 |
2005-04-06 |
버텍스 파마슈티칼스 인코포레이티드 |
Gsk-3의 억제제로서 유용한 피라졸 조성물
|
JP2006512313A
(ja)
*
|
2002-10-31 |
2006-04-13 |
アムジェン インコーポレイテッド |
抗炎症剤
|
WO2004072029A2
(en)
|
2003-02-06 |
2004-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridazines useful as inhibitors of protein kinases
|
JP2007513184A
(ja)
*
|
2003-12-04 |
2007-05-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なキノキサリン
|
DE102004005172A1
(de)
*
|
2004-02-02 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
|
WO2007022384A2
(en)
|
2005-08-18 |
2007-02-22 |
Vertex Pharmaceuticals Incorporated |
Pyrazine kinase inhibitors
|
CN103145702A
(zh)
|
2005-11-03 |
2013-06-12 |
顶点医药品公司 |
用作激酶抑制剂的氨基嘧啶
|
MX2008013205A
(es)
*
|
2006-04-14 |
2008-10-22 |
Abbott Lab |
Procedimiento para la preparacion de indazolil ureas que inhibien receptores de vanilloides del subtipo 1 (vr1).
|
NZ576750A
(en)
|
2006-11-02 |
2012-01-12 |
Vertex Pharma |
Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases
|
DE602007007985D1
(de)
|
2006-12-19 |
2010-09-02 |
Vertex Pharma |
Als inhibitoren von proteinkinasen geeignete aminopyrimidine
|
WO2008112642A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
AU2008226461A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyridines useful as inhibitors of protein kinases
|
CA2680029A1
(en)
|
2007-03-09 |
2008-09-18 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as inhibitors of protein kinases
|
AU2008240313A1
(en)
|
2007-04-13 |
2008-10-23 |
Aj Park |
Aminopyrimidines useful as kinase inhibitors
|
CN101801959A
(zh)
|
2007-05-02 |
2010-08-11 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的氨基嘧啶类化合物
|
CN101679387A
(zh)
*
|
2007-05-02 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的氨基嘧啶类化合物
|
EP2152694A2
(en)
|
2007-05-02 |
2010-02-17 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
AU2008257044A1
(en)
*
|
2007-05-24 |
2008-12-04 |
Vertex Pharmaceuticals Incorporated |
Thiazoles and pyrazoles useful as kinase inhibitors
|
WO2009018415A1
(en)
|
2007-07-31 |
2009-02-05 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
MX2011002312A
(es)
*
|
2008-09-03 |
2011-04-26 |
Vertex Pharma |
Co-cristales y formulaciones farmaceuticas que comprenden los mismos.
|
DE102009004245A1
(de)
|
2009-01-09 |
2010-07-15 |
Bayer Schering Pharma Aktiengesellschaft |
Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung
|
MX365772B
(es)
|
2012-07-24 |
2019-06-13 |
Bial Portela & Ca Sa |
Compuestos de urea y su uso como inhibidores de enzimas.
|
RU2015104103A
(ru)
*
|
2012-07-27 |
2016-09-20 |
Биал - Портела Энд К, С.А. |
Способ синтеза замещенных соединений мочевины
|
ES2640800T3
(es)
|
2013-07-24 |
2017-11-06 |
BIAL - PORTELA & Cª, S.A. |
Imidazolcarboxamidas y su uso como inhibidores de la FAAH
|